|
2024
|
Invention
|
Monoclonal antibodies against her2 epitope and methods of use thereof.
This invention provides f... |
|
|
Invention
|
Treatment of cancer using b7-h4-targeted antibody-drug conjugates. Disclosed herein are methods o... |
|
|
Invention
|
Antibody drug conjugates comprising sting agonists, combinations and methods of use. The present ... |
|
|
Invention
|
Peptide-containing linkers for antibody-drug conjugates.
The present disclosure relates generall... |
|
|
Invention
|
B7h4-targeted antibody-drug conjugates and methods of use thereof.
The present disclosure relate... |
|
|
Invention
|
Sting agonist compounds and methods of use.
The present disclosure relates to STING (Stimulator ... |
|
2023
|
Invention
|
Site specific antibody-drug conjugates with peptide-containing linkers.
The present disclosure r... |
|
|
Invention
|
B7-h4-targeted antibody-drug conjugates for the treatment of cancer.
Disclosed herein are dosing... |
|
|
Invention
|
B7-h4-targeted antibody-drug conjugates for the treatment of cancer. Disclosed herein are dosing ... |
|
|
Invention
|
B7-h4-targeted antibody-drug conjugates for the treatment of cancer |
|
|
Invention
|
Antibody drug conjugates comprising sting agonists, combinations and methods of use.
The present... |
|
|
Invention
|
Compositions and methods for predicting response to napi2b-targeted therapy.
This disclosure pro... |
|
2022
|
Invention
|
Antibody drug conjugates comprising sting agonists. The present disclosure provides scaffolds and... |
|
|
Invention
|
Antibody drug conjugates comprising sting agonists.
The present disclosure provides scaffolds an... |
|
|
Invention
|
Napi2b-targeted polymer antibody-drug conjugate for the treatment of ovarian cancer.
Disclosed h... |
|
|
Invention
|
Napi2b-targeted polymer antibody-drug conjugate for the treatment of ovarian cancer. Disclosed he... |
|
|
Invention
|
Napi2b-targeted polymer antibody-drug conjugates and methods of use thereof.
Disclose herein are... |
|
|
Invention
|
Combination therapy of carboplatin and napi2b-targeted polymer antibody-drug conjugate for the tr... |
|
|
Invention
|
B7h4-targeted antibody-drug conjugates and methods of use thereof. The present disclosure relates... |
|
|
Invention
|
B7h4-targeted antibody-drug conjugates and methods of use thereof. i.e.i.e., when expressed on a ... |
|
2021
|
Invention
|
Sting agonist compounds and methods of use. The present disclosure relates to STING (Stimulator o... |
|
|
Invention
|
Peptide-containing linkers for antibody-drug conjugates. The present disclosure relates generally... |
|
|
Invention
|
Napi2b-targeted antibody-drug conjugates and methods of use thereof.
This disclosure provides Na... |
|
|
Invention
|
Site specific antibody-drug conjugates with peptide-containing linkers. The present disclosure re... |
|
2020
|
Invention
|
Dimeric compounds as sting agonists.
The present disclosure relates to dimeric STING agonists of... |
|
|
Invention
|
Dimeric compounds as sting agonists. The present disclosure relates to dimeric STING agonists of ... |
|
|
G/S
|
Chemical and biochemical preparations, namely, antibodies
and drug conjugates for use in the man... |
|
|
Invention
|
Bis-[n-((5-carbamoyl)-1h-benzo[d]imidazol-2-yl)-pyrazol-5-carboxamide] derivatives and related co... |
|
|
G/S
|
Chemical and biochemical preparations, namely, antibodies and drug conjugates for use in the manu... |
|
|
Invention
|
Protein-polymer-drug conjugates.
A drug conjugate is provided herein. The conjugate comprises a ... |
|
2019
|
Invention
|
Cysteine engineered antibody-drug conjugates with peptide-containing linkers.
The present disclo... |
|
|
Invention
|
Cysteine engineered antibody-drug conjugates with peptide-containing linkers. The present disclos... |
|
|
Invention
|
Monoclonal antibodies against her2 epitope and methods of use thereof. This invention provides fu... |
|
|
Invention
|
Napi2b-targeted polymer antibody-drug conjugates and methods of use thereof. Disclose herein are ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
2018
|
Invention
|
Pyrrolobenzodiazepine antibody conjugates.
The present disclosure relates generally to antibody-... |
|
|
Invention
|
Pyrrolobenzodiazepine antibody conjugates. ce.g.e.g., as therapeutics and/or diagnostics. |
|
|
Invention
|
Pyrrolobenzodiazepine antibody conjugates. The present disclosure relates generally to antibody-d... |
|
2013
|
G/S
|
Biodegradable polymer drug conjugates for use in the manufacture of pharmaceuticals and drug deli... |
|
2007
|
G/S
|
Proteins, aptamers and peptides for the use as a component
of a pharmaceutical treatment of canc... |
|
2006
|
G/S
|
Research and development of therapeutics. |
|
|
G/S
|
Research and development of therapeutics |
